8-Figure Acqusition I 200+ Practice Owners I 25+ Media Placements
Cearna Aesthetics and its flagship product, Ocumend, revolutionized the aesthetic market by offering a homeopathic solution for bruising by decreasing recovery times by 50%. They received award recognition, and industry coverage and were acquired by one of the largest pharmaceutical companies in the world, Allergan.
CEARNA WANTED TO SCALE
Cearna Aesthetics initially came to The Seidel Agency seeking to grow both its customer base and brand visibility. To do that, Cearna needed to unlock the potential within the aesthetic marketplace both with B2B and B2C consumers, as well as investors.
A PARADIGM SHIFT
Targeting the right platforms with the right messaging: We started by activating the current providers, by creating a tailored business development program with key media and messaging around the new branding initiative, that bruising mattered, as it does with both surgical and non-surgical treatments.
Skyrocketing each channel: Leveraging KOLs like Dr. Sheila Nazarian, we helped deliver a single-day conversion rate record for B2B, while our DTC media campaigns increased landing page visits by 1700%, at a fraction of their previous spend.
The proof is in the product: We delivered a massive brand boost by sharing Ocumend’s results with patient testimonials, board recommendations, and media within industry coverage such as MedEsthetics, while being nominated for the “Post Surgery Product of the Year.”
OCUMEND IS LICENSED BY ALLERGAN
© 2024 The Seidel Agency